▲ Peaking
Business
🔮 fades
Why Sionna Therapeutics Stock Is Crashing 91% to a Record Low
Sionna Therapeutics shares have plummeted over 90% following the failure of a key clinical trial for its cystic fibrosis drug, SION-719.